U4133

URB597

≥98% (HPLC), fatty acid amide hydrolase (FAAH) inhibitor, powder

• Synonim(y): Cyclohexylcarbamic acid 3´-carbamoyl-biphenyl-3-yl ester
• Wzór empiryczny (zapis Hilla): C₂₀H₂₂N₂O₃
• Numer CAS: 546141-08-6
• Masa cząsteczkowa: 338.40
• UNSPSC Code: 12352200
• PubChem Substance ID: 329827629
• NACRES: NA.77
• MDL number: MFCD05863934
• Assay: ≥98% (HPLC)
• Form: powder

Właściwości

• Nazwa produktu: URB597, ≥98% (HPLC), powder
• description: Drug Control: Új pszichoaktív anyag / New psychoactive substance (Hungary), 78/2022. (XII. 28.) BM rendelet.
• Quality Segment: 100
• assay: ≥98% (HPLC)
• form: powder
• drug control: Új pszichoaktív anyag / New psychoactive substance (Hungary), 78/2022. (XII. 28.) BM rendelet
• color: white
• solubility: DMSO: soluble ~14 mg/mL
• storage temp.: 2-8°C
• SMILES string: NC(=O)c1cccc(c1)-c2cccc(OC(=O)NC3CCCCC3)c2
• InChI: 1S/C20H22N2O3/c21-19(23)16-8-4-6-14(12-16)15-7-5-11-18(13-15)25-20(24)22-17-9-2-1-3-10-17/h4-8,11-13,17H,1-3,9-10H2,(H2,21,23)(H,22,24)
• InChI key: ROFVXGGUISEHAM-UHFFFAOYSA-N

Opis

General description

URB597 binds to active sites of fatty acid amide hydrolases and inhibits their activity. URB597 alters expression of tyrosine hydroxylase and interacts with abnormal-cannabidiol (Abn-CBD) and peroxisome proliferator-activated receptors (PPARs). URB597 elicits antinociception property via cannabinoid receptor by maintaining endocannabinoid anandamide (AEA) levels. URB597 reduces abnormal hyperactivity in neurons and could be for treatment of seizures and improving synaptic plasticity.

Biochem/physiol Actions

Potent, selective fatty acid amide hydrolase (FAAH) inhibitor.

Preparation Note

URB597 is soluble in DMSO at a concentration that is approximately 14 mg/ml.

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• Klasa składowania: 11 - Combustible Solids
• WGK: WGK 3
• PPE (środki ochrony indywidualnej): Eyeshields, Gloves